Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris

PHASE2UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

May 31, 2005

Conditions
Acne Vulgaris
Interventions
DRUG

Zileuton

Trial Locations (12)

11203

SUNY Downstate Medical Center, Brooklyn

14623

Dermatology Associates of Rochester, Rochester

23507

Virginia Clinical Research, Inc., Norfolk

30263

MedaPhase, Inc., Newnan

37072

Rivergate Dermatology, Goodlettsville

40202

Dermatology Specialists, PSC, Louisville

55432

Minnesota Clinical Study Center, Fridley

77802

J&S Studies, Inc., Bryan

78759

DermResearch, Inc., Austin

87106

Academic Dermatology Associates, Albuquerque

92123

Therapeutics Clinical Research, San Diego

17033-0850

Milton S. Hersey Medical Center, Hersey

Sponsors
All Listed Sponsors
lead

Critical Therapeutics

INDUSTRY